- Market Realist•22 minutes ago
In addition to its robust strategy, Teva Pharmaceutical also boasts of an extensive presence across all levels of the value chain for its generics business.
- 24/7 Wall St.•46 minutes ago
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
- Market Realist•21 hours ago
Teva Pharmaceutical Industries plans to take advantage of market dynamics and unmet demand in generic pharmaceuticals by enacting a three-pronged strategy.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||50.23 x 1200|
|Ask||50.43 x 1000|
|Day's Range||50.12 - 51.15|
|52wk Range||48.01 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.58|
|Avg Vol (3m)||5,741,045|
|Dividend & Yield||1.36 (2.64%)|